Rapid technological advancements in the life sciences field have made automation a key focus for many laboratories, and INTEGRA Biosciences is proud to provide advanced liquid handling solutions to streamline laboratory protocols.
Novo reports ‘really powerful’ cardio, death risk reduction for semaglutide in kidney disease
Novo Nordisk’s semaglutide cut the risk of major cardiovascular events and death from multiple causes in a Phase 3 study involving patients with type 2
May 25, 2024